taphylococcus aureus is the most common pathogen involved in skin and soft tissue infections, and it is the principal cause of surgical site infections (1-3). Most of the laboratory methods for detecting S. aureus and methicillin-resistant S. aureus (MRSA) from wounds require incubation time and do not support rapid decisions for selection of the most appropriate procedural or therapeutic interventions (4-6). Therefore, wound infections often have negative impacts on patient outcomes-most commonly a delay or deterioration of wound healing potentially leading to sepsis (4, 7).
sample buffer tube (SBT). SBTs were vortexed on a multiposition vortex mixer for 60 s and placed in the BD Max instrument rack along with the BD Max StaphSR assay reagent strip and reagent tubes. The entire assembly was placed in the BD Max instrument with the BD Max PCR cartridges, and the runs were initiated. Additionally, 100 l of each ESwab sample was transferred into BBL Trypticase soy broth (TSB) with 6.5% NaCl (BD Diagnostic Systems) and incubated at 35°C for 24 h. TSB samples were saved at refrigerated temperature until culture, and PCR results were analyzed and compared. TSB samples from samples with discrepant results were plated onto both BBL CHROMagar S. aureus and BBL CHROMagar MRSA II (BD Diagnostic Systems, Sparks, MD). Colony growth was observed after 24 h of incubation at 35°C (10) . Discrepant samples were also tested by an in-housevalidated mecA and femA PCR, using previously published primers or probes (11) and by the Xpert MRSA/S. aureus skin and soft tissue infection (SSTI) assay on the GeneXpert system (Cepheid, Sunnyvale, CA), following the manufacturer's recommendations (1, 12, 13) .
Of 250 ESwab-collected wound samples tested, 159 were negative and 83 were positive for S. aureus (Table 1 ) and 194 were negative and 54 were positive for MRSA (Table 2 ) by both tests. All 54 MRSA-positive samples were also positive for S. aureus. A total of 9 samples with discrepant results between standard of care culture and the BD Max StaphSR assay were identified. Among them, eight were negative by culture and positive by the BD Max StaphSR assay for S. aureus (Table 1) . Of these culturenegative samples, one was also positive by the BD Max StaphSR assay for MRSA. Another discordant sample was positive for MRSA by culture and negative by the BD MAX StaphSR assay (Table 2) . Discrepant results were resolved with additional tests as described in Table 3 .
Skin and soft tissue infections (SSTIs) are among the most common bacterial infections managed by clinicians, S. aureus being the most common pathogen isolated from wound infection (1, 2, 5, 7). Uncomplicated SSTIs were largely managed in outpatient settings by simple incision and drainage procedures for treatment. Traditional wound management has shown to be an imprecise form of therapy for community-associated methicillin-resistant S. aureus infections. This results in increased treatment failure, recurrent infections, local or generalized spread, and other complications (3, 4, 7) . Our study evaluated the BD Max StaphSR assay to detect S. aureus and MRSA in wound samples. The BD Max StaphSR assay and culture displayed an excellent overall agreement for the detection of MRSA (99.2%) and S. aureus (96.8%) from ESwab-collected wound samples. All five S. aureus false-positive samples detected by the BD Max StaphSR assay presented threshold cycle (C T ) values of Ն38, which could indicate very low bacterial load being detected. Moreover, the BD Max StaphSR assay has the ability to yield faster results than culture and can potentially facilitate earlier treatment for wound infections. 
